首页 > 市场调查报告书 > 医疗设备

心血管设备

市场调查报告书

商品编码

1820625

全球心律不整治疗设备市场研究报告 - 产业分析、规模、份额、成长、趋势及预测（2025 年至 2033 年）

Global Arrhythmia Treatment Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年07月01日 | 出版商:

Value Market Research | 英文 130 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球心律不整治疗设备市场预计将经历显着扩张，预计 2025 年至 2033 年的年复合成长率(CAGR) 为 7.79%。根据市场分析，预计到 2033 年底市场规模将达到 164.2 亿美元，高于 2024 年的 83.6 亿美元。

受心律不整盛行率上升和设备技术进步的推动，全球心律不整治疗设备市场可望强劲成长。植入式心臟復律去颤器 (ICD)、心律调节器和导管消融系统的创新正在改善治疗效果和患者生活品质。未来的发展将侧重于微型化、无线连接和人工智慧诊断，以实现个人化和远端心臟护理。

此外，全球人口老化和心血管疾病发生率的上升也导致患者群体不断扩大。远端监控和远距医疗平台的整合正在增强植入后管理，并降低再入院率。监管审批和报销政策正在支持其更广泛的应用。随着心臟护理的发展，心律不整治疗设备市场将持续创新，提供更安全、更聪明、更有效的治疗解决方案。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美各细分市场销售分析
- 北美各国销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲各细分市场销售分析
- 欧洲各国销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区分部销售分析
- 亚太地区国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲各细分市场销售分析
- 拉丁美洲各国销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲分部销售分析
- 中东和非洲国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东和非洲其他地区销售分析

第九章：心律不整治疗设备公司的竞争格局

心律不整治疗设备市场竞争
伙伴关係/合作/协议
併购
新产品发布
其他发展

第十章：公司简介

顶级公司市占率分析
市场集中度
Abbott

公司概况
公司收入
产品
最新动态

ACS Diagnostics

公司概况
公司收入
产品
最新动态

GE HealthCare

公司概况
公司收入
产品
最新动态

Biotronik

公司概况
公司收入
产品
最新动态

IRhythm Technologies Inc.

公司概况
公司收入
产品
最新动态

Medtronic

公司概况
公司收入
产品
最新动态

Koninklijke Philips NV

公司概况
公司收入
产品
最新动态

Fukuda Denshi

公司概况
公司收入
产品
最新动态

Spacelabs Healthcare

公司概况
公司收入
产品
最新动态

AliveCor Inc

公司概况
公司收入
产品
最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，或者在私人公司的情况下可能不涵盖

简介目录图表

Product Code: VMR112115418

Global Arrhythmia Treatment Devices Market is anticipated to experience remarkable expansion, with a projected Compound Annual Growth Rate (CAGR) of 7.79% from 2025 to 2033. According to the market analysis, the market size is forecasted to reach USD 16.42 Billion by the end of 2033, up from USD 8.36 Billion in 2024.

The global arrhythmia treatment devices market is set for robust growth driven by rising prevalence of cardiac arrhythmias and advancements in device technology. Innovations in implantable cardioverter defibrillators (ICDs), pacemakers, and catheter ablation systems are improving therapeutic outcomes and patient quality of life. Future developments will focus on miniaturization, wireless connectivity, and AI-enabled diagnostics to enable personalized and remote cardiac care.

Additionally, the aging global population and increasing incidence of cardiovascular diseases are expanding the patient pool. Integration of remote monitoring and telehealth platforms is enhancing post-implantation management and reducing hospital readmissions. Regulatory approvals and reimbursement policies are supporting wider adoption. As cardiac care evolves, the arrhythmia treatment devices market will continue to innovate, delivering safer, smarter, and more effective therapeutic solutions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the Arrhythmia Treatment Devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

ECG Monitors

Implantable Monitors

Holter Monitors

Mobile Cardiac Telemetry

By Application

Bradycardia

Tachycardia

Atrial Fibrillation

Ventricular Fibrillation

Premature Contraction

Others

By End-Use

Hospitals and Clinics

Ambulatory Centers

Diagnostic Centers

Others

List of Companies Profiled in the report

Abbott, ACS Diagnostics, GE HealthCare, Biotronik, iRhythm Technologies Inc., Medtronic, Koninklijke Philips N.V., Fukuda Denshi, Spacelabs Healthcare, AliveCor Inc.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ARRHYTHMIA TREATMENT DEVICES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-Use
- 3.7.4 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ARRHYTHMIA TREATMENT DEVICES MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. ECG Monitors Historic and Forecast Sales By Regions
5.4. Implantable Monitors Historic and Forecast Sales By Regions
5.5. Holter Monitors Historic and Forecast Sales By Regions
5.6. Mobile Cardiac Telemetry Historic and Forecast Sales By Regions

6. GLOBAL ARRHYTHMIA TREATMENT DEVICES MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Bradycardia Historic and Forecast Sales By Regions
6.4. Tachycardia Historic and Forecast Sales By Regions
6.5. Atrial Fibrillation Historic and Forecast Sales By Regions
6.6. Ventricular Fibrillation Historic and Forecast Sales By Regions
6.7. Premature Contraction Historic and Forecast Sales By Regions
6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL ARRHYTHMIA TREATMENT DEVICES MARKET ANALYSIS BY END-USE

7.1. Overview By End-Use
7.2. Historical and Forecast Data Analysis By End-Use
7.3. Hospitals and Clinics Historic and Forecast Sales By Regions
7.4. Ambulatory Centers Historic and Forecast Sales By Regions
7.5. Diagnostic Centers Historic and Forecast Sales By Regions
7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL ARRHYTHMIA TREATMENT DEVICES MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE ARRHYTHMIA TREATMENT DEVICES COMPANIES

9.1. Arrhythmia Treatment Devices Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF ARRHYTHMIA TREATMENT DEVICES INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Abbott
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. ACS Diagnostics
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. GE HealthCare
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Biotronik
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. IRhythm Technologies Inc.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Medtronic
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Koninklijke Philips N.V.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Fukuda Denshi
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Spacelabs Healthcare
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. AliveCor Inc
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments